Total Payments
$519,775
2024 Payments
$109,354
Companies
32
Transactions
1,396
Medicare Patients
396
Medicare Billing
$72,930
Payment Breakdown by Category
Other$431,708 (83.1%)
Travel$42,018 (8.1%)
Food & Beverage$28,672 (5.5%)
Consulting$17,180 (3.3%)
Education$196.81 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $431,708 | 203 | 83.1% |
| Travel and Lodging | $42,018 | 181 | 8.1% |
| Food and Beverage | $28,672 | 993 | 5.5% |
| Consulting Fee | $17,180 | 6 | 3.3% |
| Education | $196.81 | 13 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $181,791 | 276 | $0 (2024) |
| Alkermes, Inc. | $111,446 | 187 | $0 (2024) |
| ITI, Inc. | $88,557 | 117 | $0 (2023) |
| ABBVIE INC. | $66,134 | 142 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $32,852 | 60 | $0 (2024) |
| Axsome Therapeutics, Inc. | $16,034 | 47 | $0 (2024) |
| Allergan, Inc. | $10,657 | 38 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $6,062 | 137 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,100 | 93 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $921.69 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109,354 | 268 | Janssen Pharmaceuticals, Inc ($42,395) |
| 2023 | $82,638 | 238 | ITI, Inc. ($43,845) |
| 2022 | $91,014 | 196 | ITI, Inc. ($34,998) |
| 2021 | $46,671 | 111 | AbbVie Inc. ($21,781) |
| 2020 | $11,037 | 62 | Allergan, Inc. ($5,327) |
| 2019 | $52,604 | 194 | Janssen Pharmaceuticals, Inc ($31,559) |
| 2018 | $57,196 | 143 | Janssen Pharmaceuticals, Inc ($28,685) |
| 2017 | $69,262 | 184 | Janssen Pharmaceuticals, Inc ($49,681) |
All Payment Transactions
1,396 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $6.97 | General |
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $2.27 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $1.57 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $150.08 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $95.32 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $23.89 | General |
| Category: Narcoplepsy | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $237.06 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $1,266.20 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $134.00 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $169.38 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 78 | 219 | $41,517 | $15,281 |
| 2022 | 2 | 92 | 283 | $54,385 | $19,057 |
| 2021 | 3 | 90 | 273 | $53,801 | $19,218 |
| 2020 | 3 | 136 | 366 | $60,463 | $19,375 |
Total Patients
396
Total Services
1,141
Medicare Billing
$72,930
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 164 | $36,080 | $12,464 | 34.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 29 | 55 | $5,437 | $2,817 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 218 | $47,960 | $16,038 | 33.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 30 | 65 | $6,425 | $3,019 | 47.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 215 | $47,300 | $16,518 | 34.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 22 | 43 | $4,251 | $2,149 | 50.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 15 | $2,250 | $549.90 | 24.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 192 | $42,240 | $11,265 | 26.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 60 | 154 | $15,223 | $7,309 | 48.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 20 | $3,000 | $801.95 | 26.7% |
About Dr. David Jahn, MD
Dr. David Jahn, MD is a Psychiatry healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508802224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Jahn, MD has received a total of $519,775 in payments from pharmaceutical and medical device companies, with $109,354 received in 2024. These payments were reported across 1,396 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($431,708).
As a Medicare-enrolled provider, Jahn has provided services to 396 Medicare beneficiaries, totaling 1,141 services with total Medicare billing of $72,930. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Toledo, OH
- Active Since 06/21/2006
- Last Updated 02/11/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1508802224
Products in Payments
- CAPLYTA (Drug) $121,408
- INVEGA SUSTENNA (Drug) $89,378
- VRAYLAR (Drug) $76,786
- INVEGA TRINZA (Drug) $75,476
- LYBALVI (Drug) $51,066
- Aristada 441 mg (Drug) $42,585
- ARISTADA (Drug) $17,779
- SPRAVATO (Drug) $16,749
- Auvelity (Drug) $16,034
- REXULTI (Drug) $5,510
- INGREZZA (Drug) $921.69
- ABILIFY MAINTENA (Drug) $729.94
- LATUDA (Drug) $594.48
- AUSTEDO (Drug) $532.31
- TRINTELLIX (Drug) $413.90
- UZEDY (Drug) $324.26
- NUEDEXTA (Drug) $303.40
- PERSERIS (Drug) $303.31
- Austedo XR (Drug) $220.90
- Hetlioz (Drug) $195.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Toledo
Dr. Irfan Ahmed, Md, MD
Psychiatry — Payments: $172,792
Psychiatry $172,792
Laurie Veltri, Pa-C, PA-C
Psychiatry — Payments: $17,595
Psychiatry $17,595
Dr. Vishwas Mashalkar, M.d, M.D
Psychiatry — Payments: $13,938
Psychiatry $13,938
Khawaja Shahzad, M.d, M.D
Psychiatry — Payments: $8,766
Psychiatry $8,766
Robert Smith, Md, MD
Psychiatry — Payments: $7,500
Psychiatry $7,500
Dr. Tim Valko, Md, MD
Psychiatry — Payments: $6,646
Psychiatry $6,646